The China market dominated the Asia Pacific AI In Medical Imaging Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $723.5 million by 2030. The Japan market is registering a CAGR of 32.5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 34.2% during (2023 - 2030).
AI algorithms analyze cardiac imaging data, such as echocardiograms, cardiac MRI scans, and angiograms, to assess cardiac function, detect cardiovascular diseases, and predict cardiac events. AI-powered cardiac imaging tools enable early detection of heart conditions, patient risk stratification, and optimization of treatment strategies, including personalized interventions and monitoring.
AI in medical imaging plays a crucial role in cancer diagnosis, staging, treatment planning, and response assessment. In addition, AI algorithms analyze imaging biomarkers, tumor morphology, and tissue characteristics to identify malignant lesions, predict tumor aggressiveness, and monitor treatment responses. AI-driven oncologic imaging tools facilitate precision medicine approaches, including targeted therapies, immunotherapy, and image-guided interventions tailored to individual patient profiles and tumor characteristics.
The expansion of the medical devices industry in India stimulates research and development initiatives to advance AI technologies for medical imaging applications. The India Brand Equity Foundation projects that by 2030, India’s medical device industry will be valued at $50 billion. This industry has attracted substantial investments over time. In FY20, foreign investments in medical devices increased by 98% year-over-year to Rs. 2,196 crore (US$301.01 million). Therefore, the market is growing due to the rise of the medical device industry and the regional use of AI technology.
Based on Technology, the market is segmented into Deep Learning, Natural Language Processing (NLP), and Others. Based on Modality, the market is segmented into CT Scan, MRI, Ultrasound, X-rays, and Nuclear Imaging. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on Application, the market is segmented into Neurology, Breast Screening, Cardiology, Respiratory & Pulmonary, Orthopedics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- Agfa-Gevaert NV
- Microsoft Corporation
- Google LLC (Alphabet Inc.)
- Intel Corporation
- NVIDIA Corporation
- Zebra Technologies Corporation
Market Report Segmentation
By Technology- Deep Learning
- Natural Language Processing (NLP)
- Others
- CT Scan
- MRI
- Ultrasound
- X-rays
- Nuclear Imaging
- Hospitals
- Diagnostic Imaging Centers
- Others
- Neurology
- Breast Screening
- Cardiology
- Respiratory & Pulmonary
- Orthopedics
- Others
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- Agfa-Gevaert NV
- Microsoft Corporation
- Google LLC (Alphabet Inc.)
- Intel Corporation
- NVIDIA Corporation
- Zebra Technologies Corporation
Methodology
LOADING...